🧪Hyponatremia Approach Pathway

Holistic approach for improving outcomes in patients with diabetes (T2D) and CKD ca. 2022 from KDIGO #Nephpearls 👉 kdigo.org/guidelines/dia…

Differential diagnosis of AKI and examples of associated urinary sediment microscopy 🔬 findings from Muner Mohamed, MD, FASN Juan Carlos Q Velez #Nephpearls 👉 shop.lww.com/Manual-of-Neph…

Additive effects of dapagliflozin and finerenone on albuminuria in “non-diabetic” CKD: an open-label randomized clinical trial ca. 2024 from CKJ #Nephpearls #Cardiorenal 👉🏼 pubmed.ncbi.nlm.nih.gov/38186886/

Don’t miss the “Best of ASN Journals” from JASN_News @CJASN ASN Kidney360 #Nephpearls #KidneyWk ✅ Ballroom 20 B/C, San Diego Convention Center 🗓️ Oct 25, Friday ⏰ 2:00 pm - 4:00 pm PST 👉🏼 journals.lww.com/asnjournals/pa…

Today, I had the privilege of presenting a poster about a patient with Pseudohypobicarbonatemia in the setting of Multiple Myeloma at #kidneywk American Society of Nephrology. Grateful for my mentors @nephrotox, Dr. Amy Patel, and Zain Haq ¦ Nephrology

Join Dr. Weir as he discusses best practices in the management of patients with dialysis-dependent (DD) chronic kidney disease (CKD) anemia. ms.spr.ly/6013oEk5c

Renin-angiotensin-aldosterone system inhibitor (RAASi) therapy provides cardiorenal protection but is often downtitrated or discontinued after a hyperkalemia episode. This study's findings suggest a potential for avoiding a first hospitalization by increasing adherence to

Notable Articles of 2024: FLOW trial In patients with type 2 diabetes and chronic kidney disease, weekly semaglutide significantly reduced risks of major kidney events, cardiovascular events, and death from any cause while slowing loss of kidney function. nej.md/44U3slP

Editors’ Choice 2024: Exercise and Cognitive Function in Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Efficacy and Harms People living with CKD are at higher risk of cognitive impairment. This study found that across the spectrum of CKD, exercise had a small

Kidney Disease in the Public Health Agenda – Why the WHO Resolution Matters. Kidney disease affects 850 million people worldwide and is projected to become the 5th leading cause of mortality by 2050. The time for action is now. At #WHA78, United Nations Member States will vote on the World Health Organization (WHO)

DOPPS Michel Jadoul Bruce Robinson Arbor Research University of Michigan - Division of Nephrology University of Michigan School of Public Health Editorial by Anneke Kramer, Rianne Boenink, and Vianda S. Stel: Improved Survival in Patients Receiving Hemodialysis Through Changes in Practice Patterns: Does This Apply to Your Country? bit.ly/KramerED24 (FREE)

I have a presentation today on contrast induced nephropathy. It was one slide:

Snapshot of IgA Nephropathy (IgAN) Pathophysiology: Mechanistic Targets 🎯 of Potential Novel Therapies from KDIGO #Nephpearls 👉 kdigo.org/guidelines/iga…

𝐄𝐫𝐲𝐭𝐡𝐫𝐨𝐩𝐨𝐢𝐞𝐭𝐢𝐧 is a glycoprotein hormone that is produced by the kidney in response to hypoxia. It stimulates the production of red cells in the bone marrow and thereby increases oxygen delivery to tissues. Synthetic, injectable erythropoietin can be administered

Urea to Treat Hyponatremia Due to Syndrome of Inappropriate Antidiuretic Hormone Secretion: A Systematic Review and Meta-Analysis bit.ly/3XM0b53 Subhash Chander, MD.,MPH Roopa Kumari Abhi Lohana Om Parkash Yaqub Nadeem Mohammed

🧵 Among adults with hypertension in primary care, bedtime administration of antihypertensive medications was safe but did not reduce cardiovascular risk. ➡️ ja.ma/4kk6CpI

"Spurring sodium reduction across our food supply is one of the most promising tools to mitigate cardiovascular morbidity and mortality." This Viewpoint examines the U.S. FDA's efforts to reduce the amount of sodium in various major food categories. ja.ma/438x0LZ

Understanding how diabetes affects the kidneys and exploring new treatment options is of critical importance. We present a special collection of articles on Diabetes and Kidney Disease: bit.ly/3wpQ6vg (FREE until July 1, 2025)

Management of hyponatremia in the patient with heart failure: Use of urine sodium (and urine potassium) to assess diuretic response from Frederik H. Verbrugge #Nephpearls #Cardiorenal #KidneyWk 2023 👉 pubmed.ncbi.nlm.nih.gov/25037309/